Literature DB >> 26916800

Transcoronary gradients of vascular miRNAs and coronary atherosclerotic plaque characteristics.

David M Leistner1, Jes-Niels Boeckel2, Sophia M Reis3, Claudia E Thome3, Roberta De Rosa1, Till Keller4, Lars Palapies2, Stephan Fichtlscherer1, Stefanie Dimmeler5, Andreas M Zeiher4.   

Abstract

AIMS: Circulating microRNAs (miRs) may reflect pathophysiologically relevant processes in the atherosclerotically diseased coronary arterial wall. Given the unmet medical need to identify patients with an unstable plaque phenotype, we determined the relation of circulating atherosclerosis-regulatory miRs with plaque phenotypes. METHODS AND
RESULTS: We assessed coronary atherosclerotic plaque burden and phenotype by optical coherence tomography in 52 patients and measured the levels of circulating miRs across the transcoronary gradient. The overall plaque load was significantly correlated with transcoronary concentration gradients of miR-126-3p (P = 0.04), miR-145-5p (P = 0.01), miR-155-5p (P < 0.01), and miR-29b-3p (P = 0.02), but not with other miRs such as miR-92a-3p. In patients with a high extent of vulnerable plaques as assessed by the presence of thin-cap fibroatheromas (TCFAs), significantly higher transcoronary gradients were observed, particularly for miR-126-3p, miR-126-5p, and miR-145-5p (all P < 0.02). Transcoronary gradients of miR-126-3p (P < 0.01), miR-126-5p (P < 0.01), miR-145-5p (P = 0.01), miR-29b-3p (P = 0.03), and miR-155-5p (P = 0.02) demonstrated a significant discriminatory power to predict the presence of TCFAs (AUC > 0.7 for all). Moreover, aortic and venous coronary sinus levels of miR-29b-3p were inversely correlated with plaque fibrosis, a finding that is consistent with the anti-fibrotic activity of miR-29b-3p.
CONCLUSION: The overall plaque burden and plaque phenotypes are associated with changes in the kinetics of miR-concentrations across the transcoronary passage. Transcoronary gradients of the anti-atherosclerotic miR-126-3p and miR-145-5p correlated with the extent of TCFAs, suggesting that instable plaques may affect the local uptake or degradation of these miRs. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Biomarker; C7-XR™ OCT system; Circulating miRNA; Coronary angiography; Coronary atherosclerotic plaque characteristics; MicroRNA; OCT; Optical coherence tomography; TCFA; Thin-cap fibroatheromas; Transcoronary miRNA gradient; Vulnerable plaque biomarker; Vulnerable plaques; miR; miR-126; miR-126-3p; miR-145; miR-145-5p; miR-155-5p; miR-29b; miR-29b-3p; miR-92a; miRNA

Mesh:

Substances:

Year:  2016        PMID: 26916800     DOI: 10.1093/eurheartj/ehw047

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  21 in total

1.  Role of TLR4 and miR-155 in peripheral blood mononuclear cell-mediated inflammatory reaction in coronary slow flow and coronary arteriosclerosis patients.

Authors:  Jiangyan Huang; Qin Yang; Longmiao He; Jun Huang
Journal:  J Clin Lab Anal       Date:  2017-04-13       Impact factor: 2.352

2.  LncRNA TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p.

Authors:  Xue Zou; Jialiang Wang; Li Tang; Qian Wen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-06-10       Impact factor: 2.416

Review 3.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

Review 4.  Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside.

Authors:  Long-Yuan Zhou; Si-Nan Lin; Florian Rieder; Min-Hu Chen; Sheng-Hong Zhang; Ren Mao
Journal:  Inflamm Bowel Dis       Date:  2021-06-15       Impact factor: 7.290

Review 5.  Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review.

Authors:  Rokas Navickas; Diane Gal; Aleksandras Laucevičius; Agnė Taparauskaitė; Monika Zdanytė; Paul Holvoet
Journal:  Cardiovasc Res       Date:  2016-06-29       Impact factor: 10.787

Review 6.  RNAi therapy to the wall of arteries and veins: anatomical, physiologic, and pharmacological considerations.

Authors:  Christoph S Nabzdyk; Leena Pradhan-Nabzdyk; Frank W LoGerfo
Journal:  J Transl Med       Date:  2017-07-28       Impact factor: 5.531

7.  Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease.

Authors:  Julien Faccini; Jean-Bernard Ruidavets; Pierre Cordelier; Frédéric Martins; Jean-José Maoret; Vanina Bongard; Jean Ferrières; Jérôme Roncalli; Meyer Elbaz; Cécile Vindis
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

8.  Kinetics of Circulating MicroRNAs in Response to Cardiac Stress in Patients With Coronary Artery Disease.

Authors:  Felix Jansen; Lisa Schäfer; Han Wang; Theresa Schmitz; Anna Flender; Robert Schueler; Christoph Hammerstingl; Georg Nickenig; Jan-Malte Sinning; Nikos Werner
Journal:  J Am Heart Assoc       Date:  2017-07-27       Impact factor: 5.501

Review 9.  Non-coding RNAs in cardiovascular cell biology and atherosclerosis.

Authors:  Francesca Fasolo; Karina Di Gregoli; Lars Maegdefessel; Jason L Johnson
Journal:  Cardiovasc Res       Date:  2019-10-01       Impact factor: 10.787

10.  Different Effects of Endothelial Extracellular Vesicles and LPS-Induced Endothelial Extracellular Vesicles on Vascular Smooth Muscle Cells: Role of Curcumin and Its Derivatives.

Authors:  Debiao Xiang; Yamei Li; Yuling Cao; Ying Huang; Lili Zhou; Xiulian Lin; Yong Qiao; Xin Li; Duanfang Liao
Journal:  Front Cardiovasc Med       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.